Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a

NCT02463409 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT02463409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02463409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
October 31, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albright hereditary osteodystrophy, pseudohypoparathyroidism type 1a